<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Parenteral empiric antibiotic options for posthysterectomy abscess</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Parenteral empiric antibiotic options for posthysterectomy abscess</h1>
<div class="graphic"><div class="figure"><div class="ttl">Parenteral empiric antibiotic options for posthysterectomy abscess</div><div class="cntnt"><table cellspacing="0"><colgroup span="2" width="50%"></colgroup> <tbody> <tr> <td class="subtitle1">Antibiotic regimen</td> <td class="subtitle1">Adult dose*</td> </tr> <tr> <td>Piperacillin-tazobactam<sup>¶</sup></td> <td>3.375 g IV every 6 hours</td> </tr> <tr class="divider_bottom"> <td colspan="2"><strong>OR</strong></td> </tr> <tr> <td>Clindamycin</td> <td>900 mg IV every 8 hours</td> </tr> <tr> <td class="sublist1" colspan="2"><strong>PLUS</strong></td> </tr> <tr> <td>Ceftriaxone</td> <td>2 g IV every 24 hours</td> </tr> <tr class="divider_bottom"> <td colspan="2"><strong>OR</strong></td> </tr> <tr> <td>Metronidazole</td> <td>500 mg IV every 8 hours</td> </tr> <tr> <td class="sublist1" colspan="2"><strong>PLUS</strong></td> </tr> <tr> <td>Ceftriaxone</td> <td>2 g IV every 24 hours</td> </tr> <tr class="divider_bottom"> <td colspan="2"><strong>OR</strong></td> </tr> <tr> <td>Ertapenem<sup>Δ</sup></td> <td>1 g IV every 24 hours</td> </tr> <tr class="divider_bottom"> <td colspan="2"><strong>OR</strong></td> </tr> <tr class="divider_bottom"> <td>Ticarcillin-clavulanate<sup>◊</sup></td> <td>3.1 g IV every 6 hours</td> </tr> <tr> <td colspan="2"><strong>Option for patients with severe hypersensitivity to penicillins or cephalosporins</strong></td> </tr> <tr> <td class="indent1">Aztreonam</td> <td>1 g IV every 8 hours</td> </tr> <tr> <td class="sublist2" colspan="2"><strong>PLUS</strong></td> </tr> <tr> <td class="indent1">Clindamycin</td> <td>900 mg IV every 8 hours</td> </tr> </tbody></table></div><div class="graphic_lgnd">These options reflect the expert opinion of UpToDate contributors and are not an exclusive list. The choice of antibiotic agent and dose should be individualized on the basis of patient history, local practice patterns, local community resistance prevalence, and availability.</div><div class="graphic_footnotes">IV: intravenously.<br/>* The doses recommended above are intended for patients with normal renal function; the doses of some of these agents must be adjusted in patients with renal insufficiency.<br/>¶ This is our preferred regimen. An extended infusion of piperacillin-tazobactam (eg, 3.375 g infused over 4 hours every 8 hours) is an alternative dosing strategy for critically ill patients or for pathogens with elevated but susceptible minimum inhibitory concentrations. Benefits over standard dosing have been suggested by some studies but not all. The extended infusion dosing regimen is at least equivalent to standard dosing and may be superior in selected patient populations.<br/>Δ Ertapenem and other carbapenems are generally reserved for patients who have suspected or documented infection with resistant gram-negative bacilli, such as extended-spectrum beta-lactamase (ESBL) producing <em>Escherichia coli </em>or <em>Klebsiella pneumoniae</em>.<br/><font class="lozenge">◊</font> Ticarcillin-clavulanate is not available in the United States.</div><div class="graphic_reference">Adapted from: Jaiyeoba O. Postoperative infections in obstetrics and gynecology. Clin Obstet Gynecol 2012; 55:904.</div><div id="graphicVersion">Graphic 97485 Version 2.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
